Label-free quantitative proteomics of CD133-positive liver cancer stem cells

Label-free quantitative proteomics of CD133-positive liver cancer stem cells

<p>Abstract</p> <p>Background</p> <p>CD133-positive liver cancer stem cells, which are characterized by their resistance to conventional chemotherapy and their tumor initiation ability at limited dilutions, have been recognized as a critical target in liver cancer thera...

Full description

Bibliographic Details
Main Authors: Tsai Sheng-Ta, Tsou Chih-Chiang, Mao Wan-Yu, Chang Wei-Chao, Han Hsin-Ying, Hsu Wen-Lian, Li Chung-Leung, Shen Chia-Ning, Chen Chung-Hsuan
Format: Article
Language:English
Published: BMC 2012-11-01
Series:Proteome Science
Subjects:
Hepatocellular carcinoma
LC-MS/MS
Liver cancer stem cells
Label-free quantitation
Online Access:http://www.proteomesci.com/content/10/1/69

Internet

http://www.proteomesci.com/content/10/1/69

Similar Items